Compare BIO-TECHNE Corp (TECH) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs ZIM Integrated Shipping Services Ltd — how do they compare? BIO-TECHNE Corp trades at $72.13 (market cap $11.24B), while ZIM Integrated Shipping Services Ltd trades at $24.5 (market cap $3.04B). The key difference: BIO-TECHNE Corp is far larger — about 3.7× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays the higher dividend (20.16%). Which is the better fit depends on your goals.
| TECH | ZIM | |
|---|---|---|
Market Cap | $11.24B | $3.04B |
Sector | Health | Industrials |
52-Week High | $72.29 | $29.27 |
52-Week Low | $43.31 | $12.44 |
Enterprise Value | $11.32B | $6.89B |
Dividend Yield | 0.44% | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
ZIM trades at $26.90, up 1.97% with strong technical momentum (bullish moving averages, RSI at 78.56 suggests overbought conditions). The stock shows mixed fundamentals with a low P/S of 0.48 and P/B of 0.79, but profitability metrics are weak (net margin 1.56%, ROE 2.52%). Recent earnings show one beat and one miss, with Q2 2026 results pending. The company faces merger uncertainty with Hapag-Lloyd amid regulatory challenges.
Outlook remains cautious with analyst consensus neutral (50% hold, 50% sell) and price target of $16.75 well below current levels. Key risks include merger failure, declining cash flow, and geopolitical tensions. The stock trades at a premium to analyst targets despite weak profitability trends, suggesting limited near-term upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
